Grant: III: Pandemic Preparedness Strategic Research Initiative
Université Laval
$100,000.00
Triggering of lung innate response to control respiratory virus infections: a cellular and molecular study
EF 2008-09
Résumé
Lung infection by influenza virus (IAV) is responsible for annual seasonal infection that affects several million people in the world, especially among the elderly. Respiratory syncytial virus (RSV) is one of the major causes of lung infection in infants during the first years of life and is associated to severe pulmonary diseases such as pneumonia and airway hyperresponsiveness. To date, attempts to develop vaccine or drugs for the treatment of those infections were found to be unsuccessful. Thus, new approaches are urgently needed to treat and even to prevent IAV and RSV infections. In this regard, the recent discovery of Toll-like receptors (TLRs) (or viral detectors) which recognize viral components may provide alternative strategy to develop new therapeutic approaches. We thus propose to evaluate the effects of new molecules that are recognized to activate viral detectors expressed in cells of lungs and to stimulate natural immunity, a process leading to viral clearance. Administration of such molecules alone or in combination with antiviral agents may be beneficial to rapidly suppress viral infection and to restore normal lung functions.
Programme
III: Pandemic Preparedness Strategic Research Initiative
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
187382
Name
Gosselin Jean
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Triggering of lung innate response to control respiratory virus infections: a cellular and molecular study
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
III: Pandemic Preparedness Strategic Research Initiative
Keyworddelim
Bronchiolitis/Pneumonia; Influenza/Respiratory Syncytial Viruses; Lung Infection; Lung Innate Immunity; Retinoic Acid-Inducible Gene I (Rig-I); Toll-Like Receptors
Abstract
Lung infection by influenza virus (IAV) is responsible for annual seasonal infection that affects several million people in the world, especially among the elderly. Respiratory syncytial virus (RSV) is one of the major causes of lung infection in infants during the first years of life and is associated to severe pulmonary diseases such as pneumonia and airway hyperresponsiveness. To date, attempts to develop vaccine or drugs for the treatment of those infections were found to be unsuccessful. Thus, new approaches are urgently needed to treat and even to prevent IAV and RSV infections. In this regard, the recent discovery of Toll-like receptors (TLRs) (or viral detectors) which recognize viral components may provide alternative strategy to develop new therapeutic approaches. We thus propose to evaluate the effects of new molecules that are recognized to activate viral detectors expressed in cells of lungs and to stimulate natural immunity, a process leading to viral clearance. Administration of such molecules alone or in combination with antiviral agents may be beneficial to rapidly suppress viral infection and to restore normal lung functions.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gosselin, Jean
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~